In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 76 for your search:
Drug:  etoposide phosphate
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631
2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: CTOP, NCT01746992
3.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 1 to 17
Sponsor: Other
Protocol IDs: CDR0000686545, GPOH-COALL-08-09, EUDRACT-2009-012758-18, EU-21076, NCT01228331
4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 25 to 65
Sponsor: Other
Protocol IDs: JALSG ALL202-O, NCT00131027
5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 30
Sponsor: NCI, Other
Protocol IDs: AALL0433, COG-AALL0433, CDR0000495359, NCT00381680
6.

Phase: Phase III
Type: Diagnostic, Treatment
Status: Active
Age: 17 and under
Sponsor: Other
Protocol IDs: CDR0000531687, EURONET-PHL-C1, EU-20703, EUDRACT-2006-000995-33, CCLG-HD-2007-10, NCT00433459
7.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: UARK 2008-01, NCT00734877
8.

Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: CCLG-ALLR3, CCLG-ALLR3, ISCRTN-45724312, EUDRACT-2004-000052-16, EU-20938, NCT00967057
9.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: Under 30 at initial diagnosis
Sponsor: NCI, Other
Protocol IDs: CDR0000649716, COG-AREN0534, AREN0534, NCT00945009
10.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: OHSU-2868, P30CA069533, 8507, SOL-04058-L, 2868, OHSU-8507, OHSU-SOL-04058-L, NCT00303849
11.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 07-154, NCT00660036
12.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 1 to 14
Sponsor: Other
Protocol IDs: 87-01-36-6853, NCT00798148
13.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 10-0910 / 201106039, NCT00906945
14.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 1 to 21
Sponsor: Other
Protocol IDs: T2008-002, NCT00981799
15.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-1758 / 201108212, NCT01000285
16.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110216, 11-C-0216, NCT01415765
17.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120003, 12-C-0003, NCT01468311
18.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: OHSU-922, ONC-02059-L, 922, 7328, OHSU-7328, OHSU-ONC-02059-L, CASE-CCF-6385, NCT00075387
19.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 59
Sponsor: Other
Protocol IDs: LL03, NCT00195871
20.

Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: MRC-TE23, EU-205107, ISRCTN53643604, EUDRACT-2004-000405-22, NCT00301782
21.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PET in DLBCL, NCT00324467
22.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: BMA-05-017-ZEV, NCT00438581
23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: GELTAMO-Z-BEAM LDGGB, EudraCT No.: 2007-003198 - 22, NCT00646750
24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: TreoALL, NCT00682305
25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 to 50
Sponsor: NCI
Protocol IDs: OSU-08066, OSU 08066, 2008C0112, DFCI-06254, NCT01005758
1     
New Search